ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
0.6372
+0.0585 (10.11%)
At close: Jul 3, 2025, 1:00 PM
0.7000
+0.0628 (9.86%)
After-hours: Jul 3, 2025, 4:58 PM EDT
ProKidney Stock Forecast
PROK's stock price has decreased by -71.55% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts that cover ProKidney stock have a consensus rating of "Hold" and an average price target of $3.5, which forecasts a 449.28% increase in the stock price over the next year. The lowest target is $1 and the highest is $6.
Price Target: $3.5 (+449.28%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for ProKidney stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Hold → Sell Downgrades $3 → $1 | Hold → Sell | Downgrades | $3 → $1 | +56.94% | Jun 30, 2025 |
| JP Morgan | JP Morgan | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Sep 30, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +841.62% | Sep 10, 2024 |
| B of A Securities | B of A Securities | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +370.81% | Sep 4, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $15 → $6 | Strong Buy | Maintains | $15 → $6 | +841.62% | Jun 10, 2024 |
Financial Forecast
Revenue This Year
117.30K
from 76.00K
Increased by 54.34%
Revenue Next Year
n/a
from 117.30K
EPS This Year
-0.57
from -0.62
EPS Next Year
-0.59
from -0.57
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 241,500 | n/a | n/a | ||
| Avg | 117,300 | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 217.8% | - | - | ||
| Avg | 54.3% | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.47 | -0.42 | -0.46 | ||
| Avg | -0.57 | -0.59 | -0.68 | ||
| Low | -0.67 | -0.77 | -0.80 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.